Overview
Jan Steyaert is a professor at Vrije Universiteit Brussel and director of the Structural Biology Brussels lab at Vrije Universiteit Brussel, as well as Deputy-Director of the Structural Biology Research Center of Flanders Institute for Biotechnology. He founded Confo Therapeutics in 2015 as a spin-off from his lab at Vrije Universiteit Brussel and Flanders Institute for Biotechnology, based on the ConfoBody technology he developed for stabilizing GPCRs in pharmacologically relevant conformations. He is also a co-founder of Ablynx and Biotalys, and won the Jacob and Louise Gabbay Award in Biotechnology and Medicine in 2022.
Career history
In the news
- Two inspiring days of exploring VUB innovation during Flanders Technology & Innovation Festival in Brussels! 🚀 This week, Vrije Universiteit Brussel took part in the Business Tracks of FTI Brussels, bringing academia and industry together for two days of expert insights, inspiring exchanges and hands-on discoveries through guided lab tours. 🧬 Health & Human | 19 October From healthcare and biotechnology to immunotherapy, VUB experts shared insights at TheMerode, while afternoon lab tours on the VUB campus gave
- Update yourself at Flanders NEXT! The central expo of the Flanders Technology & Innovation Festival is in full build-up mode, and we’re already spotting some of our own VUB innovations! From 20 October to 7 November 2026, the Nekkerhal in Mechelen will be transformed into a 6,000 m² showcase of how technology and innovation are shaping our future. 🌱 Planet Solutions 💻 DigiTech 🎨 Creative Culture 🏠 Future Living Vrije Universiteit Brussel (VUB) is proud to showcase no fewer than 17 installations at the expo, with and without
- Get a behind-the-scenes look at innovation on the VUB campus! On 19 & 20 October, Vrije Universiteit Brussel is opening its lab doors exclusively for professionals during FTI Brussels. One more week to go! Join a Fast Track tour for a unique look at our cutting-edge research and state-of-the-art facilities: Mon 19 October (afternoon) | Health & Human 🧬🤖 • Biotechnology is life • From beer to biotech: Innovation to taste and discover • Smart health: HealthTech that prevents and repairs Tue 20 October (afternoon) | Circular &
- How are Nanobodies® transforming the biotech sector worldwide? 🧬🧪 Get a sneak peek into the labs at Vrije Universiteit Brussel in our ongoing video series leading up to FTI Brussels! In this video, we spotlight the VIB-VUB Center for Structural Biology (Center for Protein Science), where groundbreaking research on Nanobodies®—unique single-domain antibody fragments discovered at VUB—is revolutionising the global biotech and pharmaceutical industries, opening up new frontiers in targeted therapeutics and diagnostics. 💡 Want to
- What does the future of health look like? 🩺❤️ Find out on October 19, when researchers, health innovators, entrepreneurs and policymakers come together at TheMerode for the specialised business track Health & Human at the Flanders Technology & Innovation Festival. Expect inspiring insights, real-world cases, and conversations that spark new connections across the health and innovation ecosystem. Vrije Universiteit Brussel is deeply integrated throughout the programme, with our experts taking the stage in panels and keynotes in the
- Don't wait for the future of your sector to arrive. Build it at the Flanders Technology & Innovation Festival in Brussels, together with Vrije Universiteit Brussel. Two days. Three sectors. One place to meet the people, ideas and innovations driving your sector forward. On October 19 and 20, FTI Brussels brings professionals together at TheMerode for three specialised business tracks: 🏙️ Circular & City: How can we make our cities more circular, resilient and liveable? ❤️ Health & Human: How can technology, innovation and
Related profiles
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.